Completion thyroidectomy: predicting bilateral disease

Journal of Otolaryngology-Head & Neck Surgery

Richard J. Payne¹  Derin Caglar³  Alex M. Mlynarek¹  Michael Hier¹  Véronique-Isabelle Forest¹  Badr Ibrahim² 

[1] Jewish General Hospital – Otolaryngology Head and Neck Surgery Clinic, 3755 Côte-Sainte-Catherine Road, Montreal H3T 1E2, QC, Canada;Division of Otolaryngology Head and Neck Surgery, McGill Thyroid Cancer Center, Jewish General Hospital, 3755 Cote Ste Catherine, Montreal H3T 1E2, QC, Canada;Department of Pathology, McGill University Health Center Glen site, 1001 Boulevard Decarie, Montreal H4A 3J1, QC, Canada

关键词: Patient information;    Decision making;    Bilateral disease;    Thyroid carcinomas;    Completion thyroidectomy;   

Others  :  1219107
DOI  :  10.1186/s40463-015-0076-4

 received in 2014-11-29, accepted in 2015-06-01,  发布年份 2015

【 摘 要 】

Introduction

It is not uncommon for patients with indeterminate thyroid nodules to undergo diagnostic hemithyroidectomy. When the final pathology determines that the nodule is in fact malignant, patients require counseling as to the whether a completion thyroidectomy is necessary.

Objectives

1. Determine the incidence of well differentiated thyroid cancer (WDTC) in the contralateral thyroid lobe in patients undergoing completion thyroidectomy.

2. Identify features of the malignant tumor in the initial resection that increase the likelihood of malignancy in the contralateral lobe.

Methods

Retrospective chart review of 97 patients who underwent hemithyroidectomy and completion thyroidectomy in a university’s teaching hospital network between 2006 and 2012. Pathology reports from both surgeries as well as patient and thyroid nodule characteristics were reviewed.

Results

Of the 97 patients, 47 (48 %) had a malignancy in the contralateral lobe. In the contralateral lobe, 42/47 (89 %) of malignancies were papillary microcarcinomas (PMC) and 15/42 (36 %) of the PMC were multifocal. Multifocal malignancies in the initial specimen had a 60 % rate of contralateral malignancy and were found to be a predictor of bilateral disease (p = 0.04) with OR = 2.74 (95 % CI: 1.11–6.79; p = 0.003) in WDTC and OR = 3.59 (95 % CI:1.35 9.48; p = 0.01) in papillary cancer specifically. There was no statistical significant correlation established for the following variables: presence of positive cervical nodes, extrathyroidal extension, positive resection margins, size and angio-lymphatic invasion. Moreover, there was no statistical correlation between any of the variants of papillary thyroid cancer and bilateral disease, even though most aggressive subtypes were found to be bilateral.

Conclusion

In this study, the rate of malignancy in the contralateral lobe was 48 %. Multifocality and presence of an aggressive subtype of papillary thyroid cancer in the initial specimen were found to be more important variables to consider in decision-making regarding completion thyroidectomy than size of the initial tumor alone.

【 授权许可】

   
2015 Ibrahim et al.

【 参考文献 】

• [1]Hegedus L. Clinical practice. The thyroid nodule. N Engl J Med. 2004; 351:1764-71.
• [2]Brito JP, Yarur AJ, Prokop LJ, McIver B, Murad MH, Montori VM. Prevalence of thyroid cancer in multinodular goiter versus single nodule: a systematic review and meta-analysis. Thyroid. 2013; 23:449-55.
• [3]Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009; 19:1167-1214.
• [4]Yoon J, Kwak J, Kim EK, Moon HJ, Kim MJ, Kim JY et al.. How to approach thyroid nodules with indeterminate cytology. Ann Surg Oncol. 2010; 17:2147-55.
• [5]Banks ND, Kowalski J, Tsai HL, Somervell H, Tufano R, Dackiw AP et al.. A diagnostic predictor model for indeterminate or suspicious thyroid FNA samples. Thyroid. 2008; 18:933-41.
• [6]Miller B, Burkey S, Lindberg G et al.. Prevalence of malignancy within cytologically indeterminate thyroid nodules. Am J Surg. 2004; 188:459-62.
• [7]Goldstein RE, Netterville JL, Burkey B, Johnson JE. Implications of follicular neoplasms, atypia, and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules. Ann Surg. 2002; 235:656-62.
• [8]Castro MR, Espiritu RP, Bahn RS, Henry MR, Gharib H, Caraballo PJ et al.. Predictors of malignancy in patients with cytologically suspicious thyroid nodules. Thyroid. 2011; 21:1191-8.
• [9]Sands NB, Karls S, Amir A, Tamilia M, Gologan O, Rochon L et al.. McGill Thyroid Nodule Score (MTNS): “rating the risk,” a novel predictive scheme for cancer risk determination. J Otolaryngol Head Neck Surg. 2011; 40 Suppl 1:S1-13.
• [10]Pasieka JL, Thompson NW, McLeod MK, Burney RE, Macha M. The incidence of bilateral well-differentiated thyroid cancer found at completion thyroidectomy. World J Surg. 1992; 16:711-6.
• [11]Kawaura M, Pathak I, Gullane PJ, Mancer K, Irish J, Brown D et al.. Multicentricity in papillary thyroid carcinoma: analysis of predictive factors. J Otolaryngol. 2001; 30:102-5.
• [12]Pacini F, Elisei R, Capezzone M, Miccoli P, Molinaro E, Basolo F et al.. Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients. Thyroid. 2001; 11:877-81.
• [13]Alzahrani AS, Al Mandil M, Chaudhary MA, Ahmed M, Mohammed GE. Frequency and predictive factors of malignancy in residual thyroid tissue and cervical lymph nodes after partial thyroidectomy for differentiated thyroid cancer. Surgery. 2002; 131:443-9.
• [14]Kim ES, Kim TY, Koh JM, Kim YI, Hong SJ, Kim WB et al.. Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation. Clin Endocrinol (Oxf). 2004; 61:145-8.
• [15]Grigsby PW, Reddy RM, Moley JF, Hall BL. Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment. Surgery. 2006; 140:1043-7.
• [16]Pitt SC, Sippel RS, Chen H. Contralateral papillary thyroid cancer: does size matter? Am J Surg. 2009; 197:342-7.
• [17]Mantinan B, Rego-Iraeta A, Larranaga A, Fluiters E, Sanchez-Sobrino P, Garcia-Mayor RV. Factors influencing the outcome of patients with incidental papillary thyroid microcarcinoma. J Thyroid Res. 2012; 2012:469397.
• [18]Kahmke R, Lee WT, Puscas L, Scher RL, Shealy MJ, Burch WM et al.. Utility of intraoperative frozen sections during thyroid surgery. Int J Otolaryngol. 2013; 2013:496138.
• [19]Huber GF, Dziegielewski P, Matthews TW, Warshawski SJ, Kmet LM, Faris P et al.. Intraoperative frozen-section analysis for thyroid nodules: a step toward clarity or confusion? Arch Otolaryngol Head Neck Surg. 2007; 133:874-81.
• [20]Cetin B, Aslan S, Hatiboglu C, Babacan B, Onder A, Celik A et al.. Frozen section in thyroid surgery: is it a necessity? Can J Surg. 2004; 47:29.
• [21]Maniakas A, Forest VI, Jozaghi Y, Saliba J, Hier MP, Mlynarek A et al.. Tumor classification in well-differentiated thyroid carcinoma and sentinel lymph node biopsy outcomes: a direct correlation. Thyroid. 2014; 24:671-4.
• [22]Kazaure H, Roman S, Sosa J. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients. Ann Surg Oncol. 2012; 19:1874-80.
• [23]Smallridge RC, Ain KB, Asa SL, Bible KC, Brierley JD, Burman KD et al.. American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid. 2012; 22:1104-39.